On May 14, 2013, a University of Washington led team announced tht DNA analysis had unearthed the origins…
On Apr. 17, 2013, researchers from the University of Washington, Broad Institute of Harvard and M.I.T. announced that…
On Mar. 27, 2013, researchers at the University of British Columbia and Canada’s Michael Smith Genome Sciences Centre…
On Nov. 8, 2012, Atossa Genetics, the Breast Health Company completed its IPO with gross proceeds of $4…
On Jul. 9, 2012, the National Institutes of Health (NIH) announced it had awarded a $65 million five…
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. By June 16, the…
On Mar. 21, 2012, the University of Washington Medical Center became the first in Pacific Northwest to discharge…
On Jan. 31, 2012, the FDA approved a KALYDECO (ivacaftor), University of Washington-tested drug to treat the genetic…
On Jan. 1, 2012 Alan Aderem, Ph.D., became president of Seattle BioMed, now known as Center for Infectious…
On Aug. 30, 2011, Amnis, a Seattle-based manufacturer of advanced cell imaging systems, announced the company had been…
On Aug. 19, 2011, the U.S. Food and Drug Administration (FDA) approved Seattle Genetics’ Adcetris (brentuximab vedotin), making…
On Feb. 22, 2011, Foster City, Calif-based Gilead Sciences and Calistoga Pharmaceuticals announced Gilead’s acquisition of Calistoga for…
In 2011, the Pacific Northwest Diabetes Research Institute began clinical trials on antioxidant drug treatments on volunteers from…
On Dec. 3, 2010, Banglore, India-based Opto Circuits announced completion of its merger with Bothell-based Cardiac Science Corp….
On Oct. 28, 2010, Emergent BioSolutions announced it had completed the acquisition of Seatte-based Trubion Pharmaceutical for upfront…
On Oct. 12, 2010, HaloSource completed its IPO on the London Stock Exchange and raised $50 million in…
On Oct. 12, 2010, Bristol-Myers Squibb Company announced it had completed its acquisition of ZymoGenetics. Bristol-Myers Squibb initiated…
On Sept. 15, 2010, Pacific Northwest Diabetes Research Institute appointed Jack Faris, Ph.D., as Chief Executive Officer. Previously,…
On Aug. 12, 2010, OriGene Technologies based in Rockville, Maryland, announced the acquisition of Blue Heron Biotechnology, a…
On Jul. 22, 2010, MDRNA announced that MDRNA shareholders approved the issuance of shares of MDRNA common stock…
On Jun. 30, 2010, SonoSite acquired VisualSonics, a Toronto-based company focused on ultra high-frequency micro-ultrasound technology, for $67.9…
On Nov. 11, 2009, the Pacific Northwest Diabetes Research Institute announced the appointment of William Hagopian, M.D., Ph.D.,…
On Oct. 8, 2009, Omeros Corp. launched an initial public offering at $10.00 per share and raised $62.1…
In Sept. 2009, Seattle Cancer Care Alliance (SCCA) House opened. A state-of-the-art, 80-room, ‘green building,’ SCCA House offers…
On Apr. 15, 2009, Oregon Health & Science University (OHSU) and the University of Washington (UW), along with…
On Nov. 21, 2008, the Washington State Academy of Sciences (WSAS) was launched. Authorized by the state legislature…
On Oct. 22, 2008, Merck announced it was closing its Rosetta Research Center and would layoff 300 employees…
On Aug. 20, 2008, Sonus Pharmaceuticals was acquired by OncoGenex Technologies in a reverse merger transaction worth $10.36…
On Jun. 18, 2008, Fred Hutch researchers described the first successful use of a human patient’s cloned infection-fighting…
Washington BioEvolution illustrates life science companies and non-profit research organization in the State of Washington by the year…